Systematic Review on the Efficacy, Effectiveness, Safety, and Immunogenicity of Monkeypox Vaccine
- PMID: 38006040
- PMCID: PMC10674429
- DOI: 10.3390/vaccines11111708
Systematic Review on the Efficacy, Effectiveness, Safety, and Immunogenicity of Monkeypox Vaccine
Abstract
Background: The variation in the reported vaccine safety and effectiveness could contribute to the high rates of vaccine hesitancy among the general population and healthcare workers in areas where monkeypox (mpox) is circulating. In this review, our objective was to evaluate the safety, immunogenicity, effectiveness, and efficacy of the mpox vaccines.
Methods: An extensive search for articles across multiple databases was performed, including searching six databases (PubMed Central, PubMed Medline, Scopus, Web of Science, Cochrane, ProQuest), two pre-print databases (European PMC Preprint and MedRxiv), and Google Scholar.
Results: A total of 4290 citations were retrieved from the included databases. Following the removal of duplicates and the initial screening of records, a total of 36 studies were included into the analysis. Additionally, we identified five more studies through manual searches, resulting in a total of 41 eligible articles for qualitative synthesis. The study findings revealed that mpox vaccines demonstrate the ability to generate adequate antibodies; however, their effectiveness may decrease over time, exhibiting varying safety profiles. Most of the included studies consistently reported substantial levels of effectiveness and efficacy against mpox. Interestingly, the number of vaccine doses administered was found to influence the degree of immunogenicity, subsequently impacting the overall effectiveness and efficacy of the vaccines. Furthermore, we found that smallpox vaccines exhibited a form of cross-protection against mpox.
Conclusions: Vaccines can be used to prevent mpox and effectively control its spread.
Keywords: monkeypox; vaccine effectiveness; vaccine efficacy; vaccine immunogenicity; vaccine safety.
Conflict of interest statement
We do not have conflict of interest associated with this publication, and there has been no financial support for this work that could have influenced its outcome. This manuscript is original, has not been previously published, and is not currently under consideration by another journal.
Figures
Similar articles
-
Global perspectives on smallpox vaccine against monkeypox: a comprehensive meta-analysis and systematic review of effectiveness, protection, safety and cross-immunogenicity.Emerg Microbes Infect. 2024 Dec;13(1):2387442. doi: 10.1080/22221751.2024.2387442. Epub 2024 Aug 16. Emerg Microbes Infect. 2024. PMID: 39082272 Free PMC article.
-
Mpox vaccine acceptance among healthcare workers: a systematic review and meta-analysis.BMC Public Health. 2024 Jan 2;24(1):4. doi: 10.1186/s12889-023-17186-2. BMC Public Health. 2024. PMID: 38166685 Free PMC article.
-
Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults: A Single-Arm Study.Life (Basel). 2023 Mar 14;13(3):787. doi: 10.3390/life13030787. Life (Basel). 2023. PMID: 36983942 Free PMC article.
-
Prevalence of intentions to receive monkeypox vaccine. A systematic review and meta-analysis.BMC Public Health. 2024 Jan 2;24(1):35. doi: 10.1186/s12889-023-17473-y. BMC Public Health. 2024. PMID: 38166776 Free PMC article.
-
Progress and prospects on vaccine development against monkeypox infection.Microb Pathog. 2023 Jul;180:106156. doi: 10.1016/j.micpath.2023.106156. Epub 2023 May 16. Microb Pathog. 2023. PMID: 37201635 Free PMC article. Review.
Cited by
-
Advancing the understanding and management of Mpox: insights into epidemiology, disease pathways, prevention, and therapeutic strategies.BMC Infect Dis. 2025 Apr 15;25(1):529. doi: 10.1186/s12879-025-10899-2. BMC Infect Dis. 2025. PMID: 40234789 Free PMC article. Review.
-
Psychosocial correlates of free Mpox vaccination intention among men who have sex with men in China: model construction and validation.J Glob Health. 2025 Apr 2;15:04070. doi: 10.7189/jogh.15.04070. J Glob Health. 2025. PMID: 40168515 Free PMC article.
-
Mpox: current knowledge and understanding-a scoping review.FEMS Microbiol Rev. 2025 Jan 14;49:fuaf025. doi: 10.1093/femsre/fuaf025. FEMS Microbiol Rev. 2025. PMID: 40489313 Free PMC article.
-
The intention of Egyptian healthcare workers to take the monkeypox vaccine: is urgent action required?BMC Health Serv Res. 2024 Oct 8;24(1):1204. doi: 10.1186/s12913-024-11147-0. BMC Health Serv Res. 2024. PMID: 39379920 Free PMC article.
-
A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge.Vaccines (Basel). 2024 Jul 26;12(8):846. doi: 10.3390/vaccines12080846. Vaccines (Basel). 2024. PMID: 39203972 Free PMC article.
References
-
- World Health Organization Mpox Outbreak. [(accessed on 25 May 2023)]. Available online: https://www.paho.org/en/mpox.
-
- World Health Organization 2022–2023 Mpox (Monkeypox) Outbreak: Global Trends. 2023. [(accessed on 25 May 2023)]. Available online: https://worldhealthorg.shinyapps.io/mpx_global/
-
- World Health Organization Fifth Meeting of the International Health Regulations (2005) (IHR) Emergency Committee on the Multi-Country Outbreak of Mpox (Monkeypox) 2023. [(accessed on 25 May 2023)]. Available online: https://www.who.int/news/item/11-05-2023-fifth-meeting-of-the-internatio...
Publication types
LinkOut - more resources
Full Text Sources